Literature DB >> 16731670

Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study.

N Low1, M Egger, J A C Sterne, R M Harbord, F Ibrahim, B Lindblom, B Herrmann.   

Abstract

OBJECTIVE: To estimate the cumulative incidence of severe complications associated with genital chlamydia infection in the general female population.
METHODS: The Uppsala Women's Cohort Study was a retrospective population based cohort study in Sweden, linking laboratory, hospital, and population registers. We estimated the cumulative incidence of hospital diagnosed pelvic inflammatory disease, ectopic pregnancy, and infertility, and used multivariable regression models to estimate hazard ratios according to screening status.
RESULTS: We analysed complete data from 43 715 women in Uppsala aged 15-24 years between January 1985 and December 1989. Follow up until the end of 1999 included 709 000 woman years and 3025 events. The cumulative incidence of pelvic inflammatory disease by age 35 years was 3.9% (95% CI 3.7% to 4.0%) overall: 5.6% (4.7% to 6.7%) in women who ever tested positive for chlamydia, 4.0% (3.7% to 4.4%) in those with negative tests, and 2.9% (2.7% to 3.2%) in those who were never screened. The corresponding figures were: for ectopic pregnancy, 2.3% (2.2% to 2.5%) overall, 2.7% (2.1% to 3.5%), 2.0% (1.8% to 2.3%), and 1.9% (1.7% to 2.1%); and for infertility, 4.1% (3.9% to 4.3%) overall, 6.7% (5.7% to 7.9%), 4.7% (4.4% to 5.1%), and 3.1% (2.8% to 3.3%). Low educational attainment was strongly associated with the development of all outcomes.
CONCLUSIONS: The incidence of severe chlamydia associated complications estimated from ours, and other population based studies, was lower than expected. Studies that incorporate data about pelvic inflammatory disease diagnosed in primary care and behavioural risk factors would further improve our understanding of the natural history of chlamydia. Our results provide reassurance for patients, but mean that the benefits of chlamydia screening programmes might have been overestimated.

Entities:  

Mesh:

Year:  2006        PMID: 16731670      PMCID: PMC2576723          DOI: 10.1136/sti.2005.017186

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  35 in total

1.  What should we do about screening for genital chlamydia?

Authors:  Nicola Low; Matthias Egger
Journal:  Int J Epidemiol       Date:  2002-10       Impact factor: 7.196

2.  Costs and effects of chlamydial screening: dynamic versus static modeling.

Authors:  Robert Welte; Maarten Postma; Reiner Leidl; Mirjam Kretzschmar
Journal:  Sex Transm Dis       Date:  2005-08       Impact factor: 2.830

3.  Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program.

Authors:  J Paavonen; M Puolakkainen; M Paukku; H Sintonen
Journal:  Obstet Gynecol       Date:  1998-08       Impact factor: 7.661

Review 4.  Programmes to reduce pelvic inflammatory disease--the Swedish experience.

Authors:  F Kamwendo; L Forslin; L Bodin; D Danielsson
Journal:  Lancet       Date:  1998       Impact factor: 79.321

5.  Comparison of acute and subclinical pelvic inflammatory disease.

Authors:  Harold C Wiesenfeld; Richard L Sweet; Roberta B Ness; Marijane A Krohn; Anthony J Amortegui; Sharon L Hillier
Journal:  Sex Transm Dis       Date:  2005-07       Impact factor: 2.830

6.  Hospitalization rates in female US Army recruits associated with a screening program for Chlamydia trachomatis.

Authors:  Kathryn L Clark; M René Howell; Yuanhzung Li; Timothy Powers; Kelly T McKee; Thomas C Quinn; Joel C Gaydos; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2002-01       Impact factor: 2.830

7.  Ectopic pregnancies and reproductive capacity after Chlamydia trachomatis positive and negative test results: a historical follow-up study.

Authors:  Berit Andersen; Lars Østergaard; Erzsebet Puho; Mette Vinther Skriver; Henrik C Schønheyder
Journal:  Sex Transm Dis       Date:  2005-06       Impact factor: 2.830

8.  Diagnosis of pelvic inflammatory disease: time for a rethink.

Authors:  I Simms; F Warburton; L Weström
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

9.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

10.  Incidence, trends, and risks of ectopic pregnancy in a population of women.

Authors:  L Weström; L P Bengtsson; P A Mårdh
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-03
View more
  40 in total

Review 1.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 2.  Vaginal discharge.

Authors:  Des Spence; Catriona Melville
Journal:  BMJ       Date:  2007-12-01

Review 3.  Current knowledge of the aetiology of human tubal ectopic pregnancy.

Authors:  J L V Shaw; S K Dey; H O D Critchley; A W Horne
Journal:  Hum Reprod Update       Date:  2010-01-12       Impact factor: 15.610

4.  A comparison of clinical features between chlamydial and non-chlamydial urethritis in men negative for gonococcal infection who attended a urological outpatient clinic in Japan.

Authors:  Toshifumi Kurahashi; Hideaki Miyake; Yuzo Nakano; Masashi Shinozaki; Nobutoshi Oka; Kazushi Tanaka; Atsushi Takenaka; Isao Hara; Soichi Arakawa; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2007-01-09       Impact factor: 2.370

5.  Proof of concept: A bioinformatic and serological screening method for identifying new peptide antigens for Chlamydia trachomatis related sequelae in women.

Authors:  Scott H Stansfield; Pooja Patel; Joseph Debattista; Charles W Armitage; Kelly Cunningham; Peter Timms; John Allan; Aruna Mittal; Wilhelmina M Huston
Journal:  Results Immunol       Date:  2013-05-13

6.  Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.

Authors:  Pippa Oakeshott; Sally Kerry; Adamma Aghaizu; Helen Atherton; Sima Hay; David Taylor-Robinson; Ian Simms; Phillip Hay
Journal:  BMJ       Date:  2010-04-08

7.  Young women's decisions to accept chlamydia screening: influences of stigma and doctor-patient interactions.

Authors:  Myles Balfe; Ruairi Brugha; Diarmuid O'Donovan; Emer O'Connell; Deirdre Vaughan
Journal:  BMC Public Health       Date:  2010-07-19       Impact factor: 3.295

8.  Association of anti-Chlamydia antibodies with ectopic pregnancy in Benin city, Nigeria: a case-control study.

Authors:  K Agholor; L Omo-Aghoja; F Okonofua
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

9.  Repeat infection with Chlamydia trachomatis: a prospective cohort study from an STI-clinic in Stockholm.

Authors:  Karin Edgardh; Sharon Kühlmann-Berenzon; Maria Grünewald; Maria Rotzen-Ostlund; Ivar Qvarnström; Jennie Everljung
Journal:  BMC Public Health       Date:  2009-06-22       Impact factor: 3.295

10.  Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study.

Authors:  Inger J Bakken; Sara Ghaderi
Journal:  BMC Infect Dis       Date:  2009-08-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.